H Hatakeyama Selected Research

H Hatakeyama Research Topics

4	Neoplasms (Cancer) 01/2018 - 02/2000
3	Hypertension (High Blood Pressure) 01/2001 - 04/2000
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2013
1	Maxillary Sinus Neoplasms 12/2013
1	Squamous Cell Carcinoma of Head and Neck 04/2010
1	Malignant Mesothelioma 10/2004
1	Nephrogenic Diabetes Insipidus 01/2001
1	Pituitary ACTH Hypersecretion 11/2000
1	Hematoma 08/2000
1	Hyperaldosteronism (Conn Syndrome) 06/2000
1	Adenoma (Adenomas) 06/2000
1	Hyperplasia 06/2000
1	Lung Neoplasms (Lung Cancer) 02/2000

2	11-beta-Hydroxysteroid Dehydrogenase Type 2 (11 beta-Hydroxysteroid Dehydrogenase Type 2)IBA 01/2001 - 11/2000
1	Bevacizumab (Avastin)FDA Link 01/2018
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	1,2-oleoylphosphatidylcholine (DOPC)IBA 01/2018
1	Histones (Histone)IBA 01/2018
1	CCCTC-Binding FactorIBA 01/2018
1	Cisplatin (Platino)FDA LinkGeneric 12/2013
1	Docetaxel (Taxotere)FDA Link 04/2010
1	Bortezomib (Velcade)FDA Link 04/2010
1	NF-kappa B (NF-kB)IBA 04/2010
1	ErbB Receptors (EGF Receptor)IBA 04/2010
1	LipidsIBA 01/2007
1	Tuberculin (PPD)IBA 01/2007
1	Matrix Metalloproteinases (MMPs)IBA 01/2007
1	Tyr(Me)-AVPIBA 01/2001
1	Arginine Vasopressin (Argipressin)IBA 01/2001
1	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2001
1	Vasopressins (Vasopressin)IBA 01/2001
1	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2000
1	Cortisone FDA Link 11/2000
1	Adrenocorticotropic Hormone (ACTH)FDA Link 11/2000
1	Capsules (Microcapsules)IBA 08/2000
1	AldosteroneIBA 06/2000
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 06/2000
1	SodiumIBA 04/2000
1	MineralocorticoidsIBA 04/2000
1	Oxidoreductases (Dehydrogenase)IBA 04/2000

2	Therapeutics 01/2018 - 01/2007
1	Radiotherapy 12/2013
1	Pneumonectomy (Lung Volume Reduction) 10/2004
1	Aftercare (After-Treatment) 02/2000